Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sleep apnea device tracked for years in 1,000 patients

NCT ID NCT06971796

Disease control Sponsor: Inspire Medical Systems, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This registry follows 1,000 people with obstructive sleep apnea who have received the Inspire implant, a device that stimulates nerves to keep the airway open during sleep. Researchers will track how well the device works over time and how consistently patients use it, using routine clinic visits. The goal is to understand real-world outcomes and adherence without adding extra tests or procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Inspire UAS System (implantable device)
What this could lead to
If successful, this registry could confirm that the Inspire device effectively controls sleep apnea over many years, helping patients avoid CPAP machines.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device works better than alternatives. Results depend on routine care, and some patients may stop using the device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Apr 2035

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients previously implanted or scheduled to be implanted with an Inspire System will be informed of the registry and given the option to participate by qualified Euro-Stim Registry staff. Up to 1,000 patients at up to 55 centers in multiple countries in the European Union and the United Kingdom will be included in the registry.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Any patient implanted with or receiving an Inspire implant, who meets the following criteria, is eligible to participate in the registry: 1. Capable of giving informed consent, as required per institution 2. Willing to return for routine clinic visits as required for Inspire therapy management Exclusion Criteria: Any patient who meets any of the following criteria will not be eligible to participate in the registry: 1. Has a life expectancy of less than one year 2. Any reason the clinician deems patient is unfit for participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea Obstructive sleep apnea (OSA)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    21 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Angers University Hospital Center

    NOT_YET_RECRUITING

    Angers, France

  • Asklepios Klinik Hamburg

    RECRUITING

    Hamburg, Germany

  • CHU Grenoble Alpes

    NOT_YET_RECRUITING

    La Tronche, France

  • CHU Saint Etienne

    NOT_YET_RECRUITING

    Saint-Priest-en-Jarez, France

  • Clinique Beausoleil

    NOT_YET_RECRUITING

    Montpellier, France

  • Clinique de la Louviere

    NOT_YET_RECRUITING

    Lille, France

  • Guy's & St Thomas' NHS Foundation Trust

    NOT_YET_RECRUITING

    London, United Kingdom

  • Hôpital d'Instruction des Armées Laveran

    NOT_YET_RECRUITING

    Marseille, France

  • Kantonnspital Baselland-Liestal

    NOT_YET_RECRUITING

    Liestal, Switzerland

  • Klinik für HNO-Heilkunde/HNO-Schlaflabor

    NOT_YET_RECRUITING

    Lübeck, Germany

  • Klinikum Klagenfurt, KABEG

    NOT_YET_RECRUITING

    Klagenfurt, Austria

  • Klinikum Rechts der Isar Technische Universität München

    RECRUITING

    Munich, Germany

  • Manchester University NHS Trust

    NOT_YET_RECRUITING

    Manchester, United Kingdom

  • Ordensklinikum Linz

    NOT_YET_RECRUITING

    Linz, Austria

  • Otto-von-Guericke-Universität Magdeburg

    NOT_YET_RECRUITING

    Magdeburg, Germany

  • Sint Lucas Andreas Ziekenhus (OLVG)

    NOT_YET_RECRUITING

    Amsterdam, Netherlands

  • St. Antonius Ziekenhuis Nieuwegein

    NOT_YET_RECRUITING

    Nieuwegein, Netherlands

  • Universitair Ziekenhuis Antwerpen

    NOT_YET_RECRUITING

    Edegem, Belgium

  • Universitatsklinikum Hamburg Eppendorf

    RECRUITING

    Hamburg, Germany

  • University College London Hospitals NHS Foundation Trust

    NOT_YET_RECRUITING

    London, United Kingdom

  • Universitäts-HNO-Klinik Mannheim

    NOT_YET_RECRUITING

    Mannheim, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.